Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

1-2-300! The biosimilar horde stands at the gate

This article was originally published in Scrip

Executive Summary

Despite claims from 'research-based' biologics manufacturers and their representatives in the EU and US that the biosimilars market is small and relatively unimportant, the age of biosimilars is clearly already upon us. A recently launched database from Datamonitor reveals a total of 556 biosimilars currently in development or being marketed globally with over 200 companies involved in the endeavour.

Advertisement

Topics

Related Companies

Advertisement
UsernamePublicRestriction

Register

SC018824

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel